Our hard working kidneys

Our hard working kidneys One of the best kidney doctor in India. Dr. Vijay Kiran from AINU. I am Dr. Vijay Kiran, a first-generation doctor hailing from Hyderabad, India.

My upbringing in an orthodox middle-class family instilled in me the values of hard work and perseverance, which have propelled me towards becoming a qualified pediatric and adult nephrologist. As a medical professional, I am passionate about promoting medicine, fitness, and wellness, with a strong belief in the power of prevention. Through my Instagram page and website, www.ourhardworkingkidneys.com, I strive to share my knowledge of kidney diseases with the general public and medical community. My focus on science and evidence-based medicine is reflected in my qualifications, which include a DM in Nephrology, DNB in Nephrology, and SCE from the Royal College, London. With 13 years of experience in treating patients with kidney diseases, I have had the privilege of serving as an Assistant Professor in Nephrology at the Nizam's Institute of Medical Sciences, Hyderabad. I am a proud member of the National Academy of Medical Sciences (MNAMS), the American Society of Nephrology, and the International Society of Nephrology. The love and support of my patients, who have honoured me with nearly 160 five-star Google reviews (Google - Dr. B. Vijay Kiran), continues to inspire me every day. Currently, I am serving as the senior consultant nephrologist, kidney transplant physician, and Medical Director - Nephrology at the Asian Institute of Nephrology and Urology (AINU) in Siliguri, the gateway to northeast India. I am always excited to meet new people and expand my network, so please feel free to connect with me at 9247701326. Thank you for taking the time to learn more about me. I look forward to connecting with you soon! Best regards,

Dr. Vijay Kiran
9247701326

Air Pollution in India: A Silent Epidemic Reshaping Health Demographics 😷Air pollution in India, dominated by fine parti...
04/12/2025

Air Pollution in India: A Silent Epidemic Reshaping Health Demographics 😷

Air pollution in India, dominated by fine particulate matter (PM2.5) and nitrogen dioxide (NO2), has emerged as a paramount public health crisis, contributing to over 2 million annual deaths—surpassing traditional leading causes like hypertension and diabetes in urban hotspots like Delhi.

Scientifically, PM2.5 infiltrates the bloodstream, inducing systemic inflammation and oxidative stress, which accelerate atherosclerosis and endothelial dysfunction, thereby elevating cardiovascular disease (CVD) risks.🫀 Recent studies link chronic exposure to a 38% rise in PM2.5-attributable deaths since 2010, with ischemic heart disease and sudden cardiac arrests surging among younger demographics (ages 30-50), altering traditional age profiles of cardiac morbidity.
In 2023, 89% of pollution-related fatalities stemmed from non-communicable diseases (NCDs), including heart attacks, where polluted air exacerbates plaque rupture and arrhythmias.

Equally alarming is the impact on renal health.🫘 Air pollutants promote glomerular injury and tubulointerstitial fibrosis via pro-inflammatory cytokines, hastening chronic kidney disease (CKD) progression, particularly in polluted northern states. This shifts demographics, disproportionately affecting urban poor and women, with CKD incidence rising 20-30% in high-AQI zones.

Overall, air pollution now rivals CVD as India's leading mortality driver, claiming 1.5-1.7 million lives yearly through cardiorenal pathways. Urgent mitigation via cleaner fuels and green policies is imperative to curb this demographic upheaval.🌿

Time to head out to less polluted second tier cities?
Suggest your solutions here.

Dr. Vijay kiran
MBBS, MD, DM (Nephrology),
DNB (Nephrology), MNAMS,
SCE (UK) Nephrology,
Fellow in pediatric nephrology.

Former Assistant professor, Department of Nephrology, Nizam’s Institute of medical sciences, Hyderabad.

Senior consultant nephrologist and kidney transplant physician, Medical Director,
Asian institute of nephrology and urology (AINU), Siliguri.

WhatsApp 9247701326

Ati Sarvatra Varjayet: Anything in Excess is Poison ⚠️The ancient Sanskrit wisdom says it best: “Ati sarvatra varjayet” ...
03/12/2025

Ati Sarvatra Varjayet: Anything in Excess is Poison ⚠️

The ancient Sanskrit wisdom says it best: “Ati sarvatra varjayet” 🕉️ — “Excess of anything should be avoided.” Balance is the secret to health, happiness, and longevity 🌿⚖️.

Too much exercise? 🏋️‍♂️ Overtraining leads to injuries, burnout, and weakened immunity 😴💀.
Even protein — the darling of gym bros — in excess damages kidneys 🦴🚫. Yes, you can overdose on chicken breast!

Drink water like a fish? 💦 Too much (hyponatremia) can cause brain swelling and seizures 🧠🌊. Even “healthy” habits turn deadly beyond limits.

Cutting salt too low? 🧂🟢 Zero-salt zealots risk fatigue, cramps, and hormonal chaos. Your body needs sodium to function!

From fasting too long ⏳ to sleeping 12 hours daily 😪, from obsessive cleanliness 🧼 to extreme minimalism 🛋️, excess in any direction backfires.

Nature loves moderation. The middle path isn’t boring — it’s brilliant ✨.

Eat mindfully 🍴, move joyfully 🏃‍♀️, rest deeply 🛌, love fiercely ❤️… but never to extremes.

Remember: Poison is in the dose ☠️💊
Even nectar becomes venom when overdone.

So live wisely.
Ati sarvatra varjayet 🙏✨

Dr. Vijay kiran
MBBS, MD, DM (Nephrology),
DNB (Nephrology), MNAMS,
SCE (UK) Nephrology,
Fellow in pediatric nephrology.

Former Assistant professor, Department of Nephrology, Nizam’s Institute of medical sciences, Hyderabad.

Senior consultant nephrologist and kidney transplant physician, Medical Director,
Asian institute of nephrology and urology (AINU), Siliguri.

WhatsApp 9247701326

26/11/2025

Save Up to ₹1 Lakh on Taxes with Section 80DDB! 💰🩺

Here’s how patients with Chronic Kidney Disease (CKD) on dialysis can claim big tax relief in India! 🇮🇳

✅ What is Section 80DDB?
A special deduction under Income Tax Act for medical treatment of specified serious diseases, including CKD requiring dialysis! 🏥

✅ Who Can Claim?
- Patients undergoing dialysis for Chronic Kidney Failure
- Available for Self, Spouse, Children, Parents, or Siblings 👨‍👩‍👧‍👦

✅ Deduction Amount:
- ₹1 Lakh – for Senior Citizens (60 years & above) 👴👵
- ₹40,000 – for others below 60 years
(Actual expense or limit, whichever is lower)

✅ No Bills? No Problem! 📄
- Just get a certificate from a government hospital or approved specialist (Nephrologist)
- Form 10-I required (easy to get!)

✅ Why It Matters:
Dialysis costs ₹20,000–₹40,000 monthly! This deduction gives huge relief to families battling CKD 💪❤️

✅ Tip:
File it with ITR-1 or ITR-2. Don’t miss this benefit! ⏰

Save taxes. Save hope. Spread the word! 🙏✨

Dr. Vijay kiran
MBBS, MD, DM (Nephrology),
DNB (Nephrology), MNAMS,
SCE (UK) Nephrology,
Fellow in pediatric nephrology.

Former Assistant professor, Department of Nephrology, Nizam’s Institute of medical sciences, Hyderabad.

Senior consultant nephrologist and kidney transplant physician, Medical Director,
Asian institute of nephrology and urology (AINU), Siliguri.

WhatsApp 9247701326

Dr. Vijay kiranMBBS, MD, DM (Nephrology), DNB (Nephrology), MNAMS, SCE (UK) Nephrology, Fellow in pediatric nephrology. ...
25/11/2025

Dr. Vijay kiran
MBBS, MD, DM (Nephrology),
DNB (Nephrology), MNAMS,
SCE (UK) Nephrology,
Fellow in pediatric nephrology.

Former Assistant professor, Department of Nephrology, Nizam’s Institute of medical sciences, Hyderabad.

Senior consultant nephrologist and kidney transplant physician, Medical Director,
Asian institute of nephrology and urology (AINU), Siliguri.

WhatsApp 9247701326

🚨 World’s Most Unhealthy Nation - INDIA? 🇮🇳  - India is now the Diabetes Capital of the World 💉 – 11.4% of adults affect...
22/11/2025

🚨 World’s Most Unhealthy Nation - INDIA? 🇮🇳

- India is now the Diabetes Capital of the World 💉 – 11.4% of adults affected (IDF 2024)

- We’ve quietly become the Cancer Capital too 🎗️ – 1 in 9 Indians faces lifetime cancer risk (Lancet 2024)

- By 2030, India will be the Kidney Failure Capital 🩺 – ~13.5 crore people already living with Chronic kidney Disease ( CKD), pushing dialysis demand sky-high

- Silent epidemic: Non-Alcoholic Fatty Liver Disease (NAFLD) now affects 1 in 3 urban Indians 🍔🍟 – the next wave of liver failure is here

India is sitting on a health time bomb.

We’re young, we’re booming, but we’re also the fastest-growing market for processed foods, sedentary jobs, and stress.

The question isn’t “Who’s next?”
The question is: “Will we act before it’s too late?”

Time to rethink:
✅ Walk 30 mins daily
✅ Cut sugar, not just in chai
✅ Annual health check-ups (non-negotiable)
✅ Sleep > Netflix

Our grandparents lived longer on dal-chawal & cycling. Maybe they were onto something.

Let’s not gift our children a legacy of hospitals.

Whose health are you taking charge of today? Drop a ❤️ if you’re starting now!

Dr. Vijay kiran
MBBS, MD, DM (Nephrology),
DNB (Nephrology), MNAMS,
SCE (UK) Nephrology,
Fellow in pediatric nephrology.

Former Assistant professor, Department of Nephrology, Nizam’s Institute of medical sciences, Hyderabad.

Senior consultant nephrologist and kidney transplant physician, Medical Director,
Asian institute of nephrology and urology (AINU), Siliguri.

WhatsApp 9247701326


🚨 The Diclofenac Paradox: A Drug That Nearly Wiped Out Vultures… But Remains in Human Medicine 🦅💊In the 1990s–2000s, vet...
20/11/2025

🚨 The Diclofenac Paradox: A Drug That Nearly Wiped Out Vultures… But Remains in Human Medicine 🦅💊

In the 1990s–2000s, veterinary diclofenac was widely used in India to relieve pain and fever in cattle, indirectly boosting milk yield. When treated livestock died, vultures scavenging the carcasses ingested high doses of the NSAID. Diclofenac caused visceral gout and acute renal failure in Gyps vulture species, leading to a catastrophic >99% population crash in just a decade—one of the fastest avian declines ever recorded.

Scientific studies (Oaks et al., Science 2004; Prakash et al., 2003) confirmed diclofenac toxicity as the primary cause. Thanks to rapid evidence-based action, India, Nepal, Pakistan and Bangladesh banned veterinary diclofenac formulations between 2006–2010 and promoted safe alternatives like meloxicam. Vulture numbers are now slowly recovering 🦅↗️.

Paradoxically, diclofenac remains a WHO essential medicine for humans, prescribed to millions annually. Yet it is one of the most nephrotoxic NSAIDs, linked to acute kidney injury, chronic kidney disease progression, and higher cardiovascular risk (EMA 2018 review; FDA warnings).

Lesson: A drug safe at human therapeutic doses can be an ecological disaster at veterinary levels.

As a nephrologist, my take is to reduce the usage in the society and indirectly protect kidney health. Avoid NSAID'S if not needed. Use only with prescription. Avoid in dehydrated states and with other nephrotoxic agents.

Dr. Vijay kiran
MBBS, MD, DM (Nephrology),
DNB (Nephrology), MNAMS,
SCE (UK) Nephrology,
Fellow in pediatric nephrology.

Former Assistant professor, Department of Nephrology, Nizam’s Institute of medical sciences, Hyderabad.

Senior consultant nephrologist and kidney transplant physician, Medical Director,
Asian institute of nephrology and urology (AINU), Siliguri.

WhatsApp 9247701326

20/11/2025

🤝 Hypertension vs. Renal Disease: Who Came First? The chicken or the egg dilemma?
A quick guide to differentiate primary hypertension causing CKD from kidney disease causing secondary hypertension 🩺

🔴 Primary Hypertension → CKD (Hypertensive Nephrosclerosis)
• Long-standing uncontrolled BP (>10–15 years)
• Usually age >50–55 years
• Mild-to-moderate proteinuria (20/HPF, dysmorphic RBCs, RBC casts)
• Asymmetric kidney size (renovascular) or large cystic kidneys (ADPKD)
• Hypokalemia, metabolic acidosis (renal tubular acidosis)
• Elevated creatinine at presentation with difficult-to-control BP

🔑 Key differentiator:
In primary HTN → kidney damage is late & subtle.
In renal disease → hypertension appears early, severe & with clear renal clues.

Early differentiation prevents irreversible damage!
Either ways get your kidney function checked.


Dr. Vijay kiran
MBBS, MD, DM (Nephrology),
DNB (Nephrology), MNAMS,
SCE (UK) Nephrology,
Fellow in pediatric nephrology.

Former Assistant professor, Department of Nephrology, Nizam’s Institute of medical sciences, Hyderabad.

Senior consultant nephrologist and kidney transplant physician, Medical Director,
Asian institute of nephrology and urology (AINU), Siliguri.

WhatsApp 9247701326

09/11/2025

Sitting is the New Smoking: Ditch the Chair for a Healthier You!

In today's desk-bound world, prolonged sitting rivals smoking as a silent killer.

It spikes heart disease and cancer risks while slowing metabolism, disrupting blood sugar and fat breakdown.

But dont worry—simple swaps can reboot your vitality.

Here's the science-backed blueprint:

1. Embrace the Standing Desk : Alternating sit-stand cuts sedentary time by up to 60 minutes daily, boosting lower-body blood flow and vascular health.

Pro tip: Limit standing to 2-4 hours to avoid back strain.

2. Walk It Out : Just 30 minutes daily slashes cardiovascular disease risk by 30% and wards off diabetes and cognitive decline.

Bonus: It torches calories, lowers stress, and amps energy!

3. Stretch for Strength : Regular stretches enhance flexibility, joint mobility, and circulation, reducing injury risk and easing muscle tension.

Small moves yield big wins—start today for a sharper, stronger tomorrow. What's your go-to desk hack?



Dr. Vijay kiran
MBBS, MD, DM (Nephrology),
DNB (Nephrology), MNAMS,
SCE (UK) Nephrology,
Fellow in pediatric nephrology.

Former Assistant professor, Department of Nephrology, Nizam’s Institute of medical sciences, Hyderabad.

Senior consultant nephrologist and kidney transplant physician, Medical Director,
Asian institute of nephrology and urology (AINU), Siliguri.

WhatsApp 9247701326

09/11/2025

NAFLD and NASH- THE NEXT BIG PANDEMIC NO ONE IS TALKING ABOUT.

Non alcoholic fatty liver disease ( NAFLD) and non alcoholic steatohepatitis(NASH).

- Around 39% of Indian adults have non-alcoholic fatty liver disease (NAFLD).
- NAFLD affects 35% of children, with rates up to 63% in obese kids.
- Urban and high-risk groups have even higher prevalence—over 50%.
- NAFLD prevalence is rising fast due to obesity, diabetes, and sedentary lifestyles.
- Around 9-32% of NAFLD patients develop non-alcoholic steatohepatitis (NASH), a more severe form.
- “Lean NAFLD” is common in India, meaning people with normal weight can still get it.
- NAFLD is linked to diabetes, hypertension, metabolic syndrome, and heart disease.
- India faces a looming health crisis with projected NAFLD cases expected to reach over 100 million by 2030.

Why is it important?

This is the leading cause of liver failure in the world.!!!

What is the solution ?

Early diagnosis, lifestyle changes, and public health measures are urgently needed.

Dr. Vijay kiran
MBBS, MD, DM (Nephrology),
DNB (Nephrology), MNAMS,
SCE (UK) Nephrology,
Fellow in pediatric nephrology.

Former Assistant professor, Department of Nephrology, Nizam’s Institute of medical sciences, Hyderabad.

Senior consultant nephrologist and kidney transplant physician, Medical Director,
Asian institute of nephrology and urology (AINU), Siliguri.

WhatsApp 9247701326

Address

Siliguri

Alerts

Be the first to know and let us send you an email when Our hard working kidneys posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Our hard working kidneys:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

One of the best Kidney doctor - Hyderabad

Kidneys are one of the most important organs in our body. They are stressed in certain situations like :

Diabetes

Hypertension

Excessive usage of pain killers